Loading...
(UNH) is set to release its FY2025Q3 earnings performance on 10/28 04:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 113.00B and an earnings per share (EPS) of 2.75 for the FY2025Q3. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings forecast suggests a Beat due to Medicare Advantage star rating improvements and margin stabilization, despite some legal and political risks.

Fact data supports cautious optimism for a Beat, driven by improving Medicare Advantage (MA) star ratings (78% in 4+ star plans for 2026), which signal better reimbursement prospects and margin stabilization. Analysts highlight MA margin recovery potential (Jefferies, Mizuho) and reiterated FY25 EPS guidance despite headwinds. However, risks remain from the DOJ’s OptumRx investigation and political uncertainty around drug pricing/ACA subsidies. While market expectations are high (38% stock gain vs. S&P 500’s 4.45%), MA improvements and cost discipline may edge results slightly above consensus.
The earnings call reflects a mixed outlook with concerns about margin recovery and membership contraction in key segments like Medicare Advantage and Medicaid. Despite some positive elements like operational improvements and strategic clarity, uncertainties remain, particularly regarding 2027 guidance and the impact of rate reductions. The Q&A highlighted management's cautious approach, avoiding specific future estimates, which adds to investor uncertainty. While some positive catalysts exist, such as value-based care and AI-driven productivity, the overall sentiment is balanced by potential challenges, leading to a neutral stock price prediction.
The earnings call summary and Q&A reveal mixed signals: strong revenue and earnings growth for OptumRx, yet membership declines and margin compressions in Medicare Advantage and Medicaid. The Q&A highlights management's optimism about long-term growth, but uncertainties about membership trends and margin recovery persist. The strategic plan indicates challenges in pricing and cost trends, offset by potential growth in value-based care. Overall, the sentiment is balanced, resulting in a neutral outlook for the stock price.
The earnings call presents several concerns: OptumHealth's earnings are below expectations, there are elevated costs due to behavioral health trends, and revenue growth is constrained by low-margin drugs. Despite some positive aspects like Medicare Advantage margin improvements, the overall tone is negative, with significant headwinds and unclear management responses. The Q&A highlights challenges in overcoming funding cuts and delayed portfolio actions, further contributing to a negative sentiment. Consequently, the stock price is likely to experience a negative movement in the coming weeks.
(UNH) is scheduled to release its FY2025Q3 earnings report onOct 28, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 113.00B in revenue and an EPS of 3.00 for 's FY2025Q3.
Intellectia's exclusive AI algorithms forecast a Beat for's FY2025Q3 earnings, with a prediction date of Oct 28, 2025. The earnings forecast suggests a Beat due to Medicare Advantage star rating improvements and margin stabilization, despite some legal and political risks.
Leverage Intellectia's AI forecast to position trades ahead of theOct 28, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!